All Stories

  1. Unexplained increase of serum carcinoembryonic antigen: don’t forget the thyroid!
  2. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis
  3. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis
  4. Clinical performance of calcitonin and procalcitonin Elecsys® immunoassays in patients with medullary thyroid carcinoma
  5. Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer
  6. 18F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
  7. Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor® Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma
  8. Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry
  9. Euthyroid Graves’ disease with spurious hyperthyroidism: a diagnostic challenge
  10. Recent Developments of 18F-FET PET in Neuro-oncology
  11. Fine-needle aspiration in all thyroid incidentalomas at 18 F-FDG PET/CT: Can EU-TIRADS revise the dogma?
  12. Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia
  13. Comparison of high intensity focused ultrasound and radioiodine for treating toxic thyroid nodules
  14. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules
  15. American Thyroid Association ultrasound system for the initial assessment of thyroid nodules: Use in stratifying the risk of malignancy of indeterminate lesions
  16. Early post-treatment risk stratification of differentiated thyroid cancer: comparison of three high-sensitive Tg assays
  17. Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma
  18. Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine?
  19. Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study
  20. Letter to the Editor: “Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation”
  21. Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review
  22. Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids
  23. Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule
  24. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review
  25. Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges
  26. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature
  27. DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper
  28. Hypercalcitoninemia and thyroid nodules
  29. When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer
  30. Serum cytokeratin 19 fragments: a dedifferentiation marker in advanced thyroid cancer
  31. Serum Procalcitonin and Calcitonin Normal Values Before and After Calcium Gluconate Infusion